TwinBeech Capital’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,415
Closed -$603K 843
2024
Q3
$603K Sell
38,415
-46,254
-55% -$701K 0.01% 567
2024
Q2
$1.14M Buy
+84,669
New +$1.73M 0.02% 391
2023
Q3
Sell
-75,819
Closed -$1.44M 827
2023
Q2
$1.44M Buy
+75,819
New +$1.35M 0.03% 415
2023
Q1
Sell
-65,766
Closed -$1.28M 813
2022
Q4
$1.28M Buy
+65,766
New +$1.28M 0.02% 487
2022
Q2
Sell
-15,129
Closed -$666K 662
2022
Q1
$666K Buy
+15,129
New +$650K 0.03% 372
2021
Q4
Sell
-79,899
Closed -$2.5M 745
2021
Q3
$2.5M Buy
+79,899
New +$3.14M 0.18% 178
2021
Q1
Sell
-14,537
Closed -$393K 613
2020
Q4
$393K Buy
+14,537
New +$374K 0.06% 322

Other funds holding ACH

TwinBeech Capital's ACH Position: Q4 2024 in Review

TwinBeech Capital sold out of Accendra Health (ACH) in Q4 2024, closing a stake of 38,415 shares — an estimated $603K sold.

TwinBeech Capital first reported a position in ACH in Q4 2020 and held it in 7 quarters. The position peaked at $2.5M in Q3 2021. 198 funds tracked by Wall St. Rank hold ACH as of Q4 2024.

  • TwinBeech Capital reported no remaining Accendra Health position as of Q4 2024 after selling out during the quarter.
  • TwinBeech Capital sold 38,415 Accendra Health shares in Q4 2024, an estimated $603K.
  • TwinBeech Capital first reported a position in Accendra Health in Q4 2020 and held it in 7 quarters.
  • TwinBeech Capital's Accendra Health position peaked at $2.5M in Q3 2021.
  • 198 funds tracked by Wall St. Rank held Accendra Health as of Q4 2024.

Based on TwinBeech Capital's 13F filing for Q4 2024, filed 14 Feb 2025.